KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elevance Health (ELV) Other Operating Expenses (2016 - 2025)

Elevance Health (ELV) has disclosed Other Operating Expenses for 17 consecutive years, with $44.0 billion as the latest value for Q3 2025.

  • On a quarterly basis, Other Operating Expenses rose 113005.13% to $44.0 billion in Q3 2025 year-over-year; TTM through Dec 2025 was $127.3 billion, a 80.47% increase, with the full-year FY2024 number at $201.0 million, changed N/A from a year prior.
  • Other Operating Expenses was $44.0 billion for Q3 2025 at Elevance Health, up from $42.5 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $44.0 billion in Q3 2025 to a low of -$39.0 million in Q3 2024.
  • A 5-year average of $32.4 billion and a median of $34.4 billion in 2022 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: tumbled 100.11% in 2024, then soared 113005.13% in 2025.
  • Elevance Health's Other Operating Expenses stood at $30.9 billion in 2021, then grew by 11.24% to $34.4 billion in 2022, then increased by 3.99% to $35.7 billion in 2023, then crashed by 100.11% to -$39.0 million in 2024, then skyrocketed by 113005.13% to $44.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Other Operating Expenses are $44.0 billion (Q3 2025), $42.5 billion (Q2 2025), and $40.8 billion (Q1 2025).